Carboxylated graphene oxide (CGO) was employed by Izadi et al. [87] in conjunction with trimethyl chitosan (TMC) and HA NPs containing HIF-1-siRNA and the CDK inhibitor Dinaciclib to downregulate HIF-1 and block CDKs in CD44-expressing cancer cells. The gene discussed is CD44; the disease is cancer.